Yongying Medical and Health's stock C net value rose 3.82%_Sina Finance_Sina.com Post date May 10, 2022 — 08:20 Post Lock Read More Yongying Medical and Health stock A net value rose 3.83% stock_Sina Finance_Sina.com Post date May 10, 2022 — 08:18 Post Lock Read More Societe Generale Healthcare Mixed A Net Worth Up 3.11% Societe Generale Post date May 6, 2022 — 09:01 Post Lock Read More Societe Generale Healthcare Hybrid C Net Worth Up 3.10% Societe Generale Post date May 6, 2022 — 09:00 Post Lock Read More Zheshang Pharmaceutical API Summary: Supply Chain ROE Improves Manufacturing End Product Upgrade Post date May 1, 2022 — 15:22 Post Lock Read More Exposure of hidden stocks of funds Post date April 25, 2022 — 07:39 Post Lock Read More Are Top-Row Funds optimistic about the A-share market outlook? The latest collection of the fund's hidden heavy holding stocks reveals the secrets, Ge Lan increases his holdings of "Yao Mao", and Xie Zhiyu aggressively buys new energy Stock Financial Industry Post date April 24, 2022 — 21:20 Post Lock Read More Are top-tier funds optimistic about the market outlook for A-shares? The latest collection of the fund's hidden heavy holding stocks reveals the secret of Ge Lan's increase in holdings of "Yao Mao" Xie Zhiyu aggressively buys new energy Post date April 24, 2022 — 21:15 Post Lock Read More Zheshang Securities gives Tianyu an overweight rating: quarter-on-quarter improvement, a new starting point in 2022 Post date April 24, 2022 — 13:15 Post Lock Read More Zheshang Securities gives Tianyu an overweight rating: quarter-to-quarter improvement, a new starting point in 2022 – yqqlm Post date April 24, 2022 — 13:15 Post Lock Read More [Graphic Quarterly Report] Comments on the 2022 First Quarterly Report of Yongying Medical and Health A Fund_Oriental Fortune Network Post date April 24, 2022 — 11:05 Post Lock Read More Zhongtai Securities: Give Tianyu a Buy rating_Stock News_Market Gold Online Post date April 22, 2022 — 14:22 Post Lock Read More Zhongtai Securities gave Tianyu a buy rating: the performance is expected to turn upward, and the new varieties of CDMO and API are expected to grow rapidly. Post date April 22, 2022 — 14:21 Post Lock Read More Zhongtai Securities gave Tianyu a buy rating: the performance is expected to turn upward, and the new varieties of CDMO and API are expected to grow rapidly – yqqlm Post date April 22, 2022 — 14:20 Post Lock Read More Tianyu Co., Ltd. announced the 2021 annual equity distribution plan to distribute 1 yuan per 10 Post date April 21, 2022 — 22:35 Post Lock Read More IPO observation Haisen Pharmaceutical's heavy single product supervision risk is high and low R&D investment may be difficult to support the road of transformation Post date April 15, 2022 — 15:18 Post Lock Read More IPO observation Haisen Pharmaceutical's heavy single product supervision risk is high and low R&D investment may be difficult to support the road of transformation. Post date April 15, 2022 — 11:18 Post Lock Read More Yongying Medical and Health stock A net value fell 4.06% stock_Sina Finance_Sina.com Post date April 14, 2022 — 07:23 Post Lock Read More Yongying Medical and Health's stock C net value fell 4.05%_Sina Finance_Sina.com Post date April 14, 2022 — 07:19 Post Lock Read More Societe Generale Healthcare Hybrid C Net Worth Down 3.10% Societe Generale Post date April 14, 2022 — 07:15 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Yongying Medical and Health stock A net value rose 3.83% stock_Sina Finance_Sina.com Post date May 10, 2022 — 08:18 Post Lock Read More Societe Generale Healthcare Mixed A Net Worth Up 3.11% Societe Generale Post date May 6, 2022 — 09:01 Post Lock Read More Societe Generale Healthcare Hybrid C Net Worth Up 3.10% Societe Generale Post date May 6, 2022 — 09:00 Post Lock Read More Zheshang Pharmaceutical API Summary: Supply Chain ROE Improves Manufacturing End Product Upgrade Post date May 1, 2022 — 15:22 Post Lock Read More Exposure of hidden stocks of funds Post date April 25, 2022 — 07:39 Post Lock Read More Are Top-Row Funds optimistic about the A-share market outlook? The latest collection of the fund's hidden heavy holding stocks reveals the secrets, Ge Lan increases his holdings of "Yao Mao", and Xie Zhiyu aggressively buys new energy Stock Financial Industry Post date April 24, 2022 — 21:20 Post Lock Read More Are top-tier funds optimistic about the market outlook for A-shares? The latest collection of the fund's hidden heavy holding stocks reveals the secret of Ge Lan's increase in holdings of "Yao Mao" Xie Zhiyu aggressively buys new energy Post date April 24, 2022 — 21:15 Post Lock Read More Zheshang Securities gives Tianyu an overweight rating: quarter-on-quarter improvement, a new starting point in 2022 Post date April 24, 2022 — 13:15 Post Lock Read More Zheshang Securities gives Tianyu an overweight rating: quarter-to-quarter improvement, a new starting point in 2022 – yqqlm Post date April 24, 2022 — 13:15 Post Lock Read More [Graphic Quarterly Report] Comments on the 2022 First Quarterly Report of Yongying Medical and Health A Fund_Oriental Fortune Network Post date April 24, 2022 — 11:05 Post Lock Read More Zhongtai Securities: Give Tianyu a Buy rating_Stock News_Market Gold Online Post date April 22, 2022 — 14:22 Post Lock Read More Zhongtai Securities gave Tianyu a buy rating: the performance is expected to turn upward, and the new varieties of CDMO and API are expected to grow rapidly. Post date April 22, 2022 — 14:21 Post Lock Read More Zhongtai Securities gave Tianyu a buy rating: the performance is expected to turn upward, and the new varieties of CDMO and API are expected to grow rapidly – yqqlm Post date April 22, 2022 — 14:20 Post Lock Read More Tianyu Co., Ltd. announced the 2021 annual equity distribution plan to distribute 1 yuan per 10 Post date April 21, 2022 — 22:35 Post Lock Read More IPO observation Haisen Pharmaceutical's heavy single product supervision risk is high and low R&D investment may be difficult to support the road of transformation Post date April 15, 2022 — 15:18 Post Lock Read More IPO observation Haisen Pharmaceutical's heavy single product supervision risk is high and low R&D investment may be difficult to support the road of transformation. Post date April 15, 2022 — 11:18 Post Lock Read More Yongying Medical and Health stock A net value fell 4.06% stock_Sina Finance_Sina.com Post date April 14, 2022 — 07:23 Post Lock Read More Yongying Medical and Health's stock C net value fell 4.05%_Sina Finance_Sina.com Post date April 14, 2022 — 07:19 Post Lock Read More Societe Generale Healthcare Hybrid C Net Worth Down 3.10% Societe Generale Post date April 14, 2022 — 07:15 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Societe Generale Healthcare Mixed A Net Worth Up 3.11% Societe Generale Post date May 6, 2022 — 09:01 Post Lock Read More Societe Generale Healthcare Hybrid C Net Worth Up 3.10% Societe Generale Post date May 6, 2022 — 09:00 Post Lock Read More Zheshang Pharmaceutical API Summary: Supply Chain ROE Improves Manufacturing End Product Upgrade Post date May 1, 2022 — 15:22 Post Lock Read More Exposure of hidden stocks of funds Post date April 25, 2022 — 07:39 Post Lock Read More Are Top-Row Funds optimistic about the A-share market outlook? The latest collection of the fund's hidden heavy holding stocks reveals the secrets, Ge Lan increases his holdings of "Yao Mao", and Xie Zhiyu aggressively buys new energy Stock Financial Industry Post date April 24, 2022 — 21:20 Post Lock Read More Are top-tier funds optimistic about the market outlook for A-shares? The latest collection of the fund's hidden heavy holding stocks reveals the secret of Ge Lan's increase in holdings of "Yao Mao" Xie Zhiyu aggressively buys new energy Post date April 24, 2022 — 21:15 Post Lock Read More Zheshang Securities gives Tianyu an overweight rating: quarter-on-quarter improvement, a new starting point in 2022 Post date April 24, 2022 — 13:15 Post Lock Read More Zheshang Securities gives Tianyu an overweight rating: quarter-to-quarter improvement, a new starting point in 2022 – yqqlm Post date April 24, 2022 — 13:15 Post Lock Read More [Graphic Quarterly Report] Comments on the 2022 First Quarterly Report of Yongying Medical and Health A Fund_Oriental Fortune Network Post date April 24, 2022 — 11:05 Post Lock Read More Zhongtai Securities: Give Tianyu a Buy rating_Stock News_Market Gold Online Post date April 22, 2022 — 14:22 Post Lock Read More Zhongtai Securities gave Tianyu a buy rating: the performance is expected to turn upward, and the new varieties of CDMO and API are expected to grow rapidly. Post date April 22, 2022 — 14:21 Post Lock Read More Zhongtai Securities gave Tianyu a buy rating: the performance is expected to turn upward, and the new varieties of CDMO and API are expected to grow rapidly – yqqlm Post date April 22, 2022 — 14:20 Post Lock Read More Tianyu Co., Ltd. announced the 2021 annual equity distribution plan to distribute 1 yuan per 10 Post date April 21, 2022 — 22:35 Post Lock Read More IPO observation Haisen Pharmaceutical's heavy single product supervision risk is high and low R&D investment may be difficult to support the road of transformation Post date April 15, 2022 — 15:18 Post Lock Read More IPO observation Haisen Pharmaceutical's heavy single product supervision risk is high and low R&D investment may be difficult to support the road of transformation. Post date April 15, 2022 — 11:18 Post Lock Read More Yongying Medical and Health stock A net value fell 4.06% stock_Sina Finance_Sina.com Post date April 14, 2022 — 07:23 Post Lock Read More Yongying Medical and Health's stock C net value fell 4.05%_Sina Finance_Sina.com Post date April 14, 2022 — 07:19 Post Lock Read More Societe Generale Healthcare Hybrid C Net Worth Down 3.10% Societe Generale Post date April 14, 2022 — 07:15 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Societe Generale Healthcare Hybrid C Net Worth Up 3.10% Societe Generale Post date May 6, 2022 — 09:00 Post Lock Read More Zheshang Pharmaceutical API Summary: Supply Chain ROE Improves Manufacturing End Product Upgrade Post date May 1, 2022 — 15:22 Post Lock Read More Exposure of hidden stocks of funds Post date April 25, 2022 — 07:39 Post Lock Read More Are Top-Row Funds optimistic about the A-share market outlook? The latest collection of the fund's hidden heavy holding stocks reveals the secrets, Ge Lan increases his holdings of "Yao Mao", and Xie Zhiyu aggressively buys new energy Stock Financial Industry Post date April 24, 2022 — 21:20 Post Lock Read More Are top-tier funds optimistic about the market outlook for A-shares? The latest collection of the fund's hidden heavy holding stocks reveals the secret of Ge Lan's increase in holdings of "Yao Mao" Xie Zhiyu aggressively buys new energy Post date April 24, 2022 — 21:15 Post Lock Read More Zheshang Securities gives Tianyu an overweight rating: quarter-on-quarter improvement, a new starting point in 2022 Post date April 24, 2022 — 13:15 Post Lock Read More Zheshang Securities gives Tianyu an overweight rating: quarter-to-quarter improvement, a new starting point in 2022 – yqqlm Post date April 24, 2022 — 13:15 Post Lock Read More [Graphic Quarterly Report] Comments on the 2022 First Quarterly Report of Yongying Medical and Health A Fund_Oriental Fortune Network Post date April 24, 2022 — 11:05 Post Lock Read More Zhongtai Securities: Give Tianyu a Buy rating_Stock News_Market Gold Online Post date April 22, 2022 — 14:22 Post Lock Read More Zhongtai Securities gave Tianyu a buy rating: the performance is expected to turn upward, and the new varieties of CDMO and API are expected to grow rapidly. Post date April 22, 2022 — 14:21 Post Lock Read More Zhongtai Securities gave Tianyu a buy rating: the performance is expected to turn upward, and the new varieties of CDMO and API are expected to grow rapidly – yqqlm Post date April 22, 2022 — 14:20 Post Lock Read More Tianyu Co., Ltd. announced the 2021 annual equity distribution plan to distribute 1 yuan per 10 Post date April 21, 2022 — 22:35 Post Lock Read More IPO observation Haisen Pharmaceutical's heavy single product supervision risk is high and low R&D investment may be difficult to support the road of transformation Post date April 15, 2022 — 15:18 Post Lock Read More IPO observation Haisen Pharmaceutical's heavy single product supervision risk is high and low R&D investment may be difficult to support the road of transformation. Post date April 15, 2022 — 11:18 Post Lock Read More Yongying Medical and Health stock A net value fell 4.06% stock_Sina Finance_Sina.com Post date April 14, 2022 — 07:23 Post Lock Read More Yongying Medical and Health's stock C net value fell 4.05%_Sina Finance_Sina.com Post date April 14, 2022 — 07:19 Post Lock Read More Societe Generale Healthcare Hybrid C Net Worth Down 3.10% Societe Generale Post date April 14, 2022 — 07:15 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Zheshang Pharmaceutical API Summary: Supply Chain ROE Improves Manufacturing End Product Upgrade Post date May 1, 2022 — 15:22 Post Lock Read More Exposure of hidden stocks of funds Post date April 25, 2022 — 07:39 Post Lock Read More Are Top-Row Funds optimistic about the A-share market outlook? The latest collection of the fund's hidden heavy holding stocks reveals the secrets, Ge Lan increases his holdings of "Yao Mao", and Xie Zhiyu aggressively buys new energy Stock Financial Industry Post date April 24, 2022 — 21:20 Post Lock Read More Are top-tier funds optimistic about the market outlook for A-shares? The latest collection of the fund's hidden heavy holding stocks reveals the secret of Ge Lan's increase in holdings of "Yao Mao" Xie Zhiyu aggressively buys new energy Post date April 24, 2022 — 21:15 Post Lock Read More Zheshang Securities gives Tianyu an overweight rating: quarter-on-quarter improvement, a new starting point in 2022 Post date April 24, 2022 — 13:15 Post Lock Read More Zheshang Securities gives Tianyu an overweight rating: quarter-to-quarter improvement, a new starting point in 2022 – yqqlm Post date April 24, 2022 — 13:15 Post Lock Read More [Graphic Quarterly Report] Comments on the 2022 First Quarterly Report of Yongying Medical and Health A Fund_Oriental Fortune Network Post date April 24, 2022 — 11:05 Post Lock Read More Zhongtai Securities: Give Tianyu a Buy rating_Stock News_Market Gold Online Post date April 22, 2022 — 14:22 Post Lock Read More Zhongtai Securities gave Tianyu a buy rating: the performance is expected to turn upward, and the new varieties of CDMO and API are expected to grow rapidly. Post date April 22, 2022 — 14:21 Post Lock Read More Zhongtai Securities gave Tianyu a buy rating: the performance is expected to turn upward, and the new varieties of CDMO and API are expected to grow rapidly – yqqlm Post date April 22, 2022 — 14:20 Post Lock Read More Tianyu Co., Ltd. announced the 2021 annual equity distribution plan to distribute 1 yuan per 10 Post date April 21, 2022 — 22:35 Post Lock Read More IPO observation Haisen Pharmaceutical's heavy single product supervision risk is high and low R&D investment may be difficult to support the road of transformation Post date April 15, 2022 — 15:18 Post Lock Read More IPO observation Haisen Pharmaceutical's heavy single product supervision risk is high and low R&D investment may be difficult to support the road of transformation. Post date April 15, 2022 — 11:18 Post Lock Read More Yongying Medical and Health stock A net value fell 4.06% stock_Sina Finance_Sina.com Post date April 14, 2022 — 07:23 Post Lock Read More Yongying Medical and Health's stock C net value fell 4.05%_Sina Finance_Sina.com Post date April 14, 2022 — 07:19 Post Lock Read More Societe Generale Healthcare Hybrid C Net Worth Down 3.10% Societe Generale Post date April 14, 2022 — 07:15 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Exposure of hidden stocks of funds Post date April 25, 2022 — 07:39 Post Lock Read More Are Top-Row Funds optimistic about the A-share market outlook? The latest collection of the fund's hidden heavy holding stocks reveals the secrets, Ge Lan increases his holdings of "Yao Mao", and Xie Zhiyu aggressively buys new energy Stock Financial Industry Post date April 24, 2022 — 21:20 Post Lock Read More Are top-tier funds optimistic about the market outlook for A-shares? The latest collection of the fund's hidden heavy holding stocks reveals the secret of Ge Lan's increase in holdings of "Yao Mao" Xie Zhiyu aggressively buys new energy Post date April 24, 2022 — 21:15 Post Lock Read More Zheshang Securities gives Tianyu an overweight rating: quarter-on-quarter improvement, a new starting point in 2022 Post date April 24, 2022 — 13:15 Post Lock Read More Zheshang Securities gives Tianyu an overweight rating: quarter-to-quarter improvement, a new starting point in 2022 – yqqlm Post date April 24, 2022 — 13:15 Post Lock Read More [Graphic Quarterly Report] Comments on the 2022 First Quarterly Report of Yongying Medical and Health A Fund_Oriental Fortune Network Post date April 24, 2022 — 11:05 Post Lock Read More Zhongtai Securities: Give Tianyu a Buy rating_Stock News_Market Gold Online Post date April 22, 2022 — 14:22 Post Lock Read More Zhongtai Securities gave Tianyu a buy rating: the performance is expected to turn upward, and the new varieties of CDMO and API are expected to grow rapidly. Post date April 22, 2022 — 14:21 Post Lock Read More Zhongtai Securities gave Tianyu a buy rating: the performance is expected to turn upward, and the new varieties of CDMO and API are expected to grow rapidly – yqqlm Post date April 22, 2022 — 14:20 Post Lock Read More Tianyu Co., Ltd. announced the 2021 annual equity distribution plan to distribute 1 yuan per 10 Post date April 21, 2022 — 22:35 Post Lock Read More IPO observation Haisen Pharmaceutical's heavy single product supervision risk is high and low R&D investment may be difficult to support the road of transformation Post date April 15, 2022 — 15:18 Post Lock Read More IPO observation Haisen Pharmaceutical's heavy single product supervision risk is high and low R&D investment may be difficult to support the road of transformation. Post date April 15, 2022 — 11:18 Post Lock Read More Yongying Medical and Health stock A net value fell 4.06% stock_Sina Finance_Sina.com Post date April 14, 2022 — 07:23 Post Lock Read More Yongying Medical and Health's stock C net value fell 4.05%_Sina Finance_Sina.com Post date April 14, 2022 — 07:19 Post Lock Read More Societe Generale Healthcare Hybrid C Net Worth Down 3.10% Societe Generale Post date April 14, 2022 — 07:15 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Are Top-Row Funds optimistic about the A-share market outlook? The latest collection of the fund's hidden heavy holding stocks reveals the secrets, Ge Lan increases his holdings of "Yao Mao", and Xie Zhiyu aggressively buys new energy Stock Financial Industry Post date April 24, 2022 — 21:20 Post Lock Read More Are top-tier funds optimistic about the market outlook for A-shares? The latest collection of the fund's hidden heavy holding stocks reveals the secret of Ge Lan's increase in holdings of "Yao Mao" Xie Zhiyu aggressively buys new energy Post date April 24, 2022 — 21:15 Post Lock Read More Zheshang Securities gives Tianyu an overweight rating: quarter-on-quarter improvement, a new starting point in 2022 Post date April 24, 2022 — 13:15 Post Lock Read More Zheshang Securities gives Tianyu an overweight rating: quarter-to-quarter improvement, a new starting point in 2022 – yqqlm Post date April 24, 2022 — 13:15 Post Lock Read More [Graphic Quarterly Report] Comments on the 2022 First Quarterly Report of Yongying Medical and Health A Fund_Oriental Fortune Network Post date April 24, 2022 — 11:05 Post Lock Read More Zhongtai Securities: Give Tianyu a Buy rating_Stock News_Market Gold Online Post date April 22, 2022 — 14:22 Post Lock Read More Zhongtai Securities gave Tianyu a buy rating: the performance is expected to turn upward, and the new varieties of CDMO and API are expected to grow rapidly. Post date April 22, 2022 — 14:21 Post Lock Read More Zhongtai Securities gave Tianyu a buy rating: the performance is expected to turn upward, and the new varieties of CDMO and API are expected to grow rapidly – yqqlm Post date April 22, 2022 — 14:20 Post Lock Read More Tianyu Co., Ltd. announced the 2021 annual equity distribution plan to distribute 1 yuan per 10 Post date April 21, 2022 — 22:35 Post Lock Read More IPO observation Haisen Pharmaceutical's heavy single product supervision risk is high and low R&D investment may be difficult to support the road of transformation Post date April 15, 2022 — 15:18 Post Lock Read More IPO observation Haisen Pharmaceutical's heavy single product supervision risk is high and low R&D investment may be difficult to support the road of transformation. Post date April 15, 2022 — 11:18 Post Lock Read More Yongying Medical and Health stock A net value fell 4.06% stock_Sina Finance_Sina.com Post date April 14, 2022 — 07:23 Post Lock Read More Yongying Medical and Health's stock C net value fell 4.05%_Sina Finance_Sina.com Post date April 14, 2022 — 07:19 Post Lock Read More Societe Generale Healthcare Hybrid C Net Worth Down 3.10% Societe Generale Post date April 14, 2022 — 07:15 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Are top-tier funds optimistic about the market outlook for A-shares? The latest collection of the fund's hidden heavy holding stocks reveals the secret of Ge Lan's increase in holdings of "Yao Mao" Xie Zhiyu aggressively buys new energy Post date April 24, 2022 — 21:15 Post Lock Read More Zheshang Securities gives Tianyu an overweight rating: quarter-on-quarter improvement, a new starting point in 2022 Post date April 24, 2022 — 13:15 Post Lock Read More Zheshang Securities gives Tianyu an overweight rating: quarter-to-quarter improvement, a new starting point in 2022 – yqqlm Post date April 24, 2022 — 13:15 Post Lock Read More [Graphic Quarterly Report] Comments on the 2022 First Quarterly Report of Yongying Medical and Health A Fund_Oriental Fortune Network Post date April 24, 2022 — 11:05 Post Lock Read More Zhongtai Securities: Give Tianyu a Buy rating_Stock News_Market Gold Online Post date April 22, 2022 — 14:22 Post Lock Read More Zhongtai Securities gave Tianyu a buy rating: the performance is expected to turn upward, and the new varieties of CDMO and API are expected to grow rapidly. Post date April 22, 2022 — 14:21 Post Lock Read More Zhongtai Securities gave Tianyu a buy rating: the performance is expected to turn upward, and the new varieties of CDMO and API are expected to grow rapidly – yqqlm Post date April 22, 2022 — 14:20 Post Lock Read More Tianyu Co., Ltd. announced the 2021 annual equity distribution plan to distribute 1 yuan per 10 Post date April 21, 2022 — 22:35 Post Lock Read More IPO observation Haisen Pharmaceutical's heavy single product supervision risk is high and low R&D investment may be difficult to support the road of transformation Post date April 15, 2022 — 15:18 Post Lock Read More IPO observation Haisen Pharmaceutical's heavy single product supervision risk is high and low R&D investment may be difficult to support the road of transformation. Post date April 15, 2022 — 11:18 Post Lock Read More Yongying Medical and Health stock A net value fell 4.06% stock_Sina Finance_Sina.com Post date April 14, 2022 — 07:23 Post Lock Read More Yongying Medical and Health's stock C net value fell 4.05%_Sina Finance_Sina.com Post date April 14, 2022 — 07:19 Post Lock Read More Societe Generale Healthcare Hybrid C Net Worth Down 3.10% Societe Generale Post date April 14, 2022 — 07:15 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Zheshang Securities gives Tianyu an overweight rating: quarter-on-quarter improvement, a new starting point in 2022 Post date April 24, 2022 — 13:15 Post Lock Read More Zheshang Securities gives Tianyu an overweight rating: quarter-to-quarter improvement, a new starting point in 2022 – yqqlm Post date April 24, 2022 — 13:15 Post Lock Read More [Graphic Quarterly Report] Comments on the 2022 First Quarterly Report of Yongying Medical and Health A Fund_Oriental Fortune Network Post date April 24, 2022 — 11:05 Post Lock Read More Zhongtai Securities: Give Tianyu a Buy rating_Stock News_Market Gold Online Post date April 22, 2022 — 14:22 Post Lock Read More Zhongtai Securities gave Tianyu a buy rating: the performance is expected to turn upward, and the new varieties of CDMO and API are expected to grow rapidly. Post date April 22, 2022 — 14:21 Post Lock Read More Zhongtai Securities gave Tianyu a buy rating: the performance is expected to turn upward, and the new varieties of CDMO and API are expected to grow rapidly – yqqlm Post date April 22, 2022 — 14:20 Post Lock Read More Tianyu Co., Ltd. announced the 2021 annual equity distribution plan to distribute 1 yuan per 10 Post date April 21, 2022 — 22:35 Post Lock Read More IPO observation Haisen Pharmaceutical's heavy single product supervision risk is high and low R&D investment may be difficult to support the road of transformation Post date April 15, 2022 — 15:18 Post Lock Read More IPO observation Haisen Pharmaceutical's heavy single product supervision risk is high and low R&D investment may be difficult to support the road of transformation. Post date April 15, 2022 — 11:18 Post Lock Read More Yongying Medical and Health stock A net value fell 4.06% stock_Sina Finance_Sina.com Post date April 14, 2022 — 07:23 Post Lock Read More Yongying Medical and Health's stock C net value fell 4.05%_Sina Finance_Sina.com Post date April 14, 2022 — 07:19 Post Lock Read More Societe Generale Healthcare Hybrid C Net Worth Down 3.10% Societe Generale Post date April 14, 2022 — 07:15 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Zheshang Securities gives Tianyu an overweight rating: quarter-to-quarter improvement, a new starting point in 2022 – yqqlm Post date April 24, 2022 — 13:15 Post Lock Read More [Graphic Quarterly Report] Comments on the 2022 First Quarterly Report of Yongying Medical and Health A Fund_Oriental Fortune Network Post date April 24, 2022 — 11:05 Post Lock Read More Zhongtai Securities: Give Tianyu a Buy rating_Stock News_Market Gold Online Post date April 22, 2022 — 14:22 Post Lock Read More Zhongtai Securities gave Tianyu a buy rating: the performance is expected to turn upward, and the new varieties of CDMO and API are expected to grow rapidly. Post date April 22, 2022 — 14:21 Post Lock Read More Zhongtai Securities gave Tianyu a buy rating: the performance is expected to turn upward, and the new varieties of CDMO and API are expected to grow rapidly – yqqlm Post date April 22, 2022 — 14:20 Post Lock Read More Tianyu Co., Ltd. announced the 2021 annual equity distribution plan to distribute 1 yuan per 10 Post date April 21, 2022 — 22:35 Post Lock Read More IPO observation Haisen Pharmaceutical's heavy single product supervision risk is high and low R&D investment may be difficult to support the road of transformation Post date April 15, 2022 — 15:18 Post Lock Read More IPO observation Haisen Pharmaceutical's heavy single product supervision risk is high and low R&D investment may be difficult to support the road of transformation. Post date April 15, 2022 — 11:18 Post Lock Read More Yongying Medical and Health stock A net value fell 4.06% stock_Sina Finance_Sina.com Post date April 14, 2022 — 07:23 Post Lock Read More Yongying Medical and Health's stock C net value fell 4.05%_Sina Finance_Sina.com Post date April 14, 2022 — 07:19 Post Lock Read More Societe Generale Healthcare Hybrid C Net Worth Down 3.10% Societe Generale Post date April 14, 2022 — 07:15 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
[Graphic Quarterly Report] Comments on the 2022 First Quarterly Report of Yongying Medical and Health A Fund_Oriental Fortune Network Post date April 24, 2022 — 11:05 Post Lock Read More Zhongtai Securities: Give Tianyu a Buy rating_Stock News_Market Gold Online Post date April 22, 2022 — 14:22 Post Lock Read More Zhongtai Securities gave Tianyu a buy rating: the performance is expected to turn upward, and the new varieties of CDMO and API are expected to grow rapidly. Post date April 22, 2022 — 14:21 Post Lock Read More Zhongtai Securities gave Tianyu a buy rating: the performance is expected to turn upward, and the new varieties of CDMO and API are expected to grow rapidly – yqqlm Post date April 22, 2022 — 14:20 Post Lock Read More Tianyu Co., Ltd. announced the 2021 annual equity distribution plan to distribute 1 yuan per 10 Post date April 21, 2022 — 22:35 Post Lock Read More IPO observation Haisen Pharmaceutical's heavy single product supervision risk is high and low R&D investment may be difficult to support the road of transformation Post date April 15, 2022 — 15:18 Post Lock Read More IPO observation Haisen Pharmaceutical's heavy single product supervision risk is high and low R&D investment may be difficult to support the road of transformation. Post date April 15, 2022 — 11:18 Post Lock Read More Yongying Medical and Health stock A net value fell 4.06% stock_Sina Finance_Sina.com Post date April 14, 2022 — 07:23 Post Lock Read More Yongying Medical and Health's stock C net value fell 4.05%_Sina Finance_Sina.com Post date April 14, 2022 — 07:19 Post Lock Read More Societe Generale Healthcare Hybrid C Net Worth Down 3.10% Societe Generale Post date April 14, 2022 — 07:15 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Zhongtai Securities: Give Tianyu a Buy rating_Stock News_Market Gold Online Post date April 22, 2022 — 14:22 Post Lock Read More Zhongtai Securities gave Tianyu a buy rating: the performance is expected to turn upward, and the new varieties of CDMO and API are expected to grow rapidly. Post date April 22, 2022 — 14:21 Post Lock Read More Zhongtai Securities gave Tianyu a buy rating: the performance is expected to turn upward, and the new varieties of CDMO and API are expected to grow rapidly – yqqlm Post date April 22, 2022 — 14:20 Post Lock Read More Tianyu Co., Ltd. announced the 2021 annual equity distribution plan to distribute 1 yuan per 10 Post date April 21, 2022 — 22:35 Post Lock Read More IPO observation Haisen Pharmaceutical's heavy single product supervision risk is high and low R&D investment may be difficult to support the road of transformation Post date April 15, 2022 — 15:18 Post Lock Read More IPO observation Haisen Pharmaceutical's heavy single product supervision risk is high and low R&D investment may be difficult to support the road of transformation. Post date April 15, 2022 — 11:18 Post Lock Read More Yongying Medical and Health stock A net value fell 4.06% stock_Sina Finance_Sina.com Post date April 14, 2022 — 07:23 Post Lock Read More Yongying Medical and Health's stock C net value fell 4.05%_Sina Finance_Sina.com Post date April 14, 2022 — 07:19 Post Lock Read More Societe Generale Healthcare Hybrid C Net Worth Down 3.10% Societe Generale Post date April 14, 2022 — 07:15 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Zhongtai Securities gave Tianyu a buy rating: the performance is expected to turn upward, and the new varieties of CDMO and API are expected to grow rapidly. Post date April 22, 2022 — 14:21 Post Lock Read More Zhongtai Securities gave Tianyu a buy rating: the performance is expected to turn upward, and the new varieties of CDMO and API are expected to grow rapidly – yqqlm Post date April 22, 2022 — 14:20 Post Lock Read More Tianyu Co., Ltd. announced the 2021 annual equity distribution plan to distribute 1 yuan per 10 Post date April 21, 2022 — 22:35 Post Lock Read More IPO observation Haisen Pharmaceutical's heavy single product supervision risk is high and low R&D investment may be difficult to support the road of transformation Post date April 15, 2022 — 15:18 Post Lock Read More IPO observation Haisen Pharmaceutical's heavy single product supervision risk is high and low R&D investment may be difficult to support the road of transformation. Post date April 15, 2022 — 11:18 Post Lock Read More Yongying Medical and Health stock A net value fell 4.06% stock_Sina Finance_Sina.com Post date April 14, 2022 — 07:23 Post Lock Read More Yongying Medical and Health's stock C net value fell 4.05%_Sina Finance_Sina.com Post date April 14, 2022 — 07:19 Post Lock Read More Societe Generale Healthcare Hybrid C Net Worth Down 3.10% Societe Generale Post date April 14, 2022 — 07:15 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Zhongtai Securities gave Tianyu a buy rating: the performance is expected to turn upward, and the new varieties of CDMO and API are expected to grow rapidly – yqqlm Post date April 22, 2022 — 14:20 Post Lock Read More Tianyu Co., Ltd. announced the 2021 annual equity distribution plan to distribute 1 yuan per 10 Post date April 21, 2022 — 22:35 Post Lock Read More IPO observation Haisen Pharmaceutical's heavy single product supervision risk is high and low R&D investment may be difficult to support the road of transformation Post date April 15, 2022 — 15:18 Post Lock Read More IPO observation Haisen Pharmaceutical's heavy single product supervision risk is high and low R&D investment may be difficult to support the road of transformation. Post date April 15, 2022 — 11:18 Post Lock Read More Yongying Medical and Health stock A net value fell 4.06% stock_Sina Finance_Sina.com Post date April 14, 2022 — 07:23 Post Lock Read More Yongying Medical and Health's stock C net value fell 4.05%_Sina Finance_Sina.com Post date April 14, 2022 — 07:19 Post Lock Read More Societe Generale Healthcare Hybrid C Net Worth Down 3.10% Societe Generale Post date April 14, 2022 — 07:15 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Tianyu Co., Ltd. announced the 2021 annual equity distribution plan to distribute 1 yuan per 10 Post date April 21, 2022 — 22:35 Post Lock Read More IPO observation Haisen Pharmaceutical's heavy single product supervision risk is high and low R&D investment may be difficult to support the road of transformation Post date April 15, 2022 — 15:18 Post Lock Read More IPO observation Haisen Pharmaceutical's heavy single product supervision risk is high and low R&D investment may be difficult to support the road of transformation. Post date April 15, 2022 — 11:18 Post Lock Read More Yongying Medical and Health stock A net value fell 4.06% stock_Sina Finance_Sina.com Post date April 14, 2022 — 07:23 Post Lock Read More Yongying Medical and Health's stock C net value fell 4.05%_Sina Finance_Sina.com Post date April 14, 2022 — 07:19 Post Lock Read More Societe Generale Healthcare Hybrid C Net Worth Down 3.10% Societe Generale Post date April 14, 2022 — 07:15 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
IPO observation Haisen Pharmaceutical's heavy single product supervision risk is high and low R&D investment may be difficult to support the road of transformation Post date April 15, 2022 — 15:18 Post Lock Read More IPO observation Haisen Pharmaceutical's heavy single product supervision risk is high and low R&D investment may be difficult to support the road of transformation. Post date April 15, 2022 — 11:18 Post Lock Read More Yongying Medical and Health stock A net value fell 4.06% stock_Sina Finance_Sina.com Post date April 14, 2022 — 07:23 Post Lock Read More Yongying Medical and Health's stock C net value fell 4.05%_Sina Finance_Sina.com Post date April 14, 2022 — 07:19 Post Lock Read More Societe Generale Healthcare Hybrid C Net Worth Down 3.10% Societe Generale Post date April 14, 2022 — 07:15 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
IPO observation Haisen Pharmaceutical's heavy single product supervision risk is high and low R&D investment may be difficult to support the road of transformation. Post date April 15, 2022 — 11:18 Post Lock Read More Yongying Medical and Health stock A net value fell 4.06% stock_Sina Finance_Sina.com Post date April 14, 2022 — 07:23 Post Lock Read More Yongying Medical and Health's stock C net value fell 4.05%_Sina Finance_Sina.com Post date April 14, 2022 — 07:19 Post Lock Read More Societe Generale Healthcare Hybrid C Net Worth Down 3.10% Societe Generale Post date April 14, 2022 — 07:15 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Yongying Medical and Health stock A net value fell 4.06% stock_Sina Finance_Sina.com Post date April 14, 2022 — 07:23 Post Lock Read More Yongying Medical and Health's stock C net value fell 4.05%_Sina Finance_Sina.com Post date April 14, 2022 — 07:19 Post Lock Read More Societe Generale Healthcare Hybrid C Net Worth Down 3.10% Societe Generale Post date April 14, 2022 — 07:15 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Yongying Medical and Health's stock C net value fell 4.05%_Sina Finance_Sina.com Post date April 14, 2022 — 07:19 Post Lock Read More Societe Generale Healthcare Hybrid C Net Worth Down 3.10% Societe Generale Post date April 14, 2022 — 07:15 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Societe Generale Healthcare Hybrid C Net Worth Down 3.10% Societe Generale Post date April 14, 2022 — 07:15 Post Lock Read More
Caishen.CoCaishen.Co